Abstract
Objective
As transcatheter aortic valve implantation (TAVI) may become a potential treatment for high-risk patients with aortic stenosis (AS), evaluation of outcomes after open aortic valve replacement (AVR) in elderly patients is warranted. We documented early and late outcomes after isolated AVR in octogenarians compared with younger age groups.
Methods
From January 2007 to December 2012, 136 patients underwent isolated AVR for AS (mean age 71.3 years, 39 % males) and were classified into two groups (octogenarians and non-octogenarians). Twenty-four percent were aged 80 years or older. Forty-six percent of all patients were in New York Heart Association functional class III–IV. The estimated Society of Thoracic Surgeons and Japan operative mortalities were 3.4 and 2.5 %, respectively.
Result
The 30-day mortality was 0 %. One in-hospital death occurred from low output syndrome and congestive heart failure in the non-octogenarian group. Postoperative morbidity was not statistically significant different between the age groups. All of the patients—with the exception of one case of in-hospital death and one patient who was transferred to another hospital—were discharged (postoperative length of stay, 16.4 days). The actuarial survival for 3 years by age group was 89.8 % in octogenarians compared with 93.2 % in non-octogenarians.
Conclusion
Recent results show that isolated AVR for severe AS can be performed with a low operative mortality and morbidity regardless of age. TAVI may be an alternative for high-risk patients, but isolated AVR remains the standard intervention for AS even in increased age.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ross J Jr, Braunwald E. Aortic stenosis. Circulation. 1968;38(suppl V):61–7.
Varadarajan P, Kapoor N, Bansal RC, Pai RG. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged > or =80 years. Eur J Cardiothorac Surg. 2006;30:722–7.
ACC/AHA. Guidelines for the management of patients with valvular heart disease. Circulation. 2006;2006(114):e84–231.
Brown JM, O’Braien SM, Wu C, Sikora JAH, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons national database. J Thorac Cardiovasc Surg. 2009;137:82–90.
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231–43.
Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111:3290–5.
Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis first human case description. Circulation. 2002;106:3006–8.
Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755–63.
Gilard M, Eltchaninoff M, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, for the FRANCE 2 Investigators, et al. Registry of Transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705–15.
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, for the PARTNER Trial Investigators, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.
Rankin JS, Hammill BG, Ferguson TB Jr, Glower DD, O’Brien SM, DeLong ER, et al. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg. 2006;131:547–57.
Pierard S, Seldrum S, Meester C, Pasquet A, Gerber B, Vancraeynest D, et al. Incidence, determinants, and prognostic impact of operative refusal or denial in octogenarians with severe aortic stenosis. Ann Thorac Surg. 2011;91:1107–12.
Olsson M, Granstrom L, Lindblom D, Rosenqvist M, Ryden L. Aortic valve replacement in octogenarians with aortic stenosis: a case–control study. J Am Coll Cardio. 1992;20:1512–6.
Amano J, Kuwano H, Yokomise H. Thoracic and cardiovascular surgery in Japan during 2009: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2013;61:578–607.
Sasaki Y, Hirai H, Hosono M, Bito Y, Nakahira A, Suehiro Y, et al. Adding coronary artery bypass grafting to aortic valve replacement increases operative mortality for elderly (70 years and older) patients with aortic stenosis. Gen Thorac Cardiovasc Surg. 2013;61:626–31.
Yamane K, Hirose H, Youdelman BA, Bogar LJ, Diehl JT. Conventional aortic valve replacement for elderly patients in the current era. Circ J. 2011;75:2692–8.
Malaisrie SC, McCarthy PM, McGee EC, Lee R, Rigolin VH, Davidson CJ, Beohar N, et al. Contemporary perioperative results of isolated aortic valve replacement for aortic stenosis. Ann Thorac Surg. 2010;89:751–7.
Thourani VH, Myung R, Kilgo P, Thompson K, Puskas JD, Lattouf OM, et al. Long-term outcomes after isolated aortic valve replacement in octogenarians: a modern perspective. Ann Thorac Surg. 2008;86:1458–65.
Conflict of interest
The authors have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented at The 66th Annual Scientific Meeting of The Japanese Association for Thoracic Surgery.
Rights and permissions
About this article
Cite this article
Koyama, Y., Sawada, K., Goto, Y. et al. Early and mid-term results of isolated aortic valve replacement for aortic stenosis in octogenarians. Gen Thorac Cardiovasc Surg 63, 216–221 (2015). https://doi.org/10.1007/s11748-014-0498-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-014-0498-3